Envision Healthcare Corporation (EVHC) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP decreased its holdings in Envision Healthcare Corporation (NYSE:EVHC) by 1.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,633,958 shares of the company’s stock after selling 24,181 shares during the period. Dimensional Fund Advisors LP owned about 1.39% of Envision Healthcare Corporation worth $102,396,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the company. Commonwealth Bank of Australia increased its stake in shares of Envision Healthcare Corporation by 24.3% in the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after acquiring an additional 410 shares during the last quarter. Ameritas Investment Partners Inc. acquired a new stake in Envision Healthcare Corporation during the first quarter valued at $172,000. LMR Partners LLP acquired a new stake in Envision Healthcare Corporation during the second quarter valued at $205,000. Nordea Investment Management AB boosted its position in Envision Healthcare Corporation by 3.7% during the first quarter. Nordea Investment Management AB now owns 3,341 shares of the company’s stock valued at $205,000 after purchasing an additional 120 shares during the last quarter. Finally, OLD Mutual Customised Solutions Proprietary Ltd. boosted its position in Envision Healthcare Corporation by 54.5% during the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 3,401 shares of the company’s stock valued at $209,000 after purchasing an additional 1,200 shares during the last quarter. Institutional investors own 64.75% of the company’s stock.
Envision Healthcare Corporation (NYSE:EVHC) opened at 44.85 on Wednesday. The stock’s 50 day moving average price is $48.46 and its 200-day moving average price is $55.85. Envision Healthcare Corporation has a one year low of $42.50 and a one year high of $74.75. The firm’s market cap is $5.25 billion.
Envision Healthcare Corporation (NYSE:EVHC) last announced its quarterly earnings data on Monday, August 7th. The company reported $0.79 EPS for the quarter, topping the Zacks’ consensus estimate of $0.75 by $0.04. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. During the same quarter in the previous year, the firm posted $0.34 earnings per share. The firm’s revenue for the quarter was up 156.7% on a year-over-year basis. Analysts forecast that Envision Healthcare Corporation will post $1.40 earnings per share for the current year.
Envision Healthcare Corporation announced that its Board of Directors has initiated a stock repurchase plan on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.
Several research analysts have weighed in on the company. Zacks Investment Research raised Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Mizuho cut their price target on Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research note on Wednesday, August 9th. BidaskClub lowered Envision Healthcare Corporation from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 price target on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Finally, Royal Bank Of Canada boosted their price target on Envision Healthcare Corporation from $72.00 to $77.00 and gave the company an “outperform” rating in a research note on Tuesday, June 27th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Envision Healthcare Corporation presently has a consensus rating of “Buy” and an average target price of $77.25.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.